Depression in the medically ill: management considerations

Related Experiment Videos

D L Evans1, J Staab, H Ward

  • 1Department of Psychiatry, University of Florida College of Medicine, Gainesville 32610, USA.

Depression and Anxiety
|January 1, 1996
PubMed

Insights

Managing depression in patients with coronary artery disease (CAD), cancer, or HIV is crucial. Antidepressant therapy, particularly SSRIs, can improve outcomes and quality of life while minimizing risks associated with older antidepressants.

Area of Science:

  • Medical management
  • Psychiatry
  • Cardiology
  • Oncology
  • Infectious Diseases

Background:

  • Depression frequently co-occurs with serious medical conditions like coronary artery disease (CAD), cancer, and HIV.
  • Major depression is linked to increased mortality in CAD patients, potentially via reduced heart rate variability.
  • Certain antidepressants carry risks; tricyclic antidepressants (TCAs) may increase sudden death risk and decrease heart rate variability.

Purpose of the Study:

  • To review the management of depression in patients with CAD, cancer, and HIV.
  • To discuss the efficacy and safety of different antidepressant classes in these patient populations.
  • To highlight the role of psychosocial interventions in managing depression in these conditions.

Main Methods:

  • Literature review of studies on depression management in CAD, cancer, and HIV.
  • Analysis of the impact of depression on mortality and quality of life.
  • Evaluation of antidepressant therapies, including TCAs, SSRIs, and newer agents.
  • Consideration of non-pharmacological interventions like social support and coping skills.

Main Results:

  • Antidepressant therapy is effective for improving quality of life in cancer and HIV patients.
  • SSRIs and newer antidepressants are preferred due to fewer adverse anticholinergic and cardiovascular effects compared to TCAs.
  • Psychosocial interventions can positively influence outcomes in cancer and HIV patients.
  • Depression management in CAD requires careful consideration of cardiac risks associated with certain antidepressants.

Conclusions:

  • Effective management of depression in patients with CAD, cancer, and HIV is essential for improving outcomes.
  • SSRIs and newer agents offer a safer alternative to TCAs for depressed patients with medical comorbidities.
  • Integrating psychosocial support alongside pharmacotherapy can enhance patient well-being and coping mechanisms.

Related Concept Videos

Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation